Carregando...
New treatment options for metastatic renal cell carcinoma with prior anti-angiogenesis therapy
Angiogenesis is a critical process in the progression of advanced renal cell carcinoma. Agents targeting angiogenesis have played a primary role in the treatment of metastatic renal cell carcinoma. However, resistance to anti-angiogenesis therapy almost always occurs, and major progress has been mad...
Na minha lista:
| Publicado no: | J Hematol Oncol |
|---|---|
| Principais autores: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BioMed Central
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5288948/ https://ncbi.nlm.nih.gov/pubmed/28153029 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13045-016-0374-y |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|